Skip to main content
Thorax logoLink to Thorax
. 1980 May;35(5):379–383. doi: 10.1136/thx.35.5.379

Sputum and blood concentrations of cefuroxime in lower respiratory tract infection.

C W Havard, R P Bax, T C Samanta, R M Pearson, W Brumfitt, J M Hamilton-Miller, C H Dash
PMCID: PMC471295  PMID: 7434289

Abstract

A detailed pharmacokinetic study of cefuroxime has been carried out. Levels of cefuroxime were determined in the blood, sputum, saliva, and urine of 23 patients receiving parenteral cefuroxime eight hourly for chest infections. Profiles were obtained after the first dose and on the final (fifth) day of treatment. Antibiotic levels in the sputum reached 0.8 mg/l within one hour of the first injection, and were maintained close to this value for six hours. There was a build-up by the fifth day, mean cefuroxime concentrations at this time reaching 1.8 mg/l. This concentration was maintained for a prolonged period. Salivary concentrations were detectable but low (maximum mean value was 0.6 mg/l). Concentrations of antibiotic were significantly higher in the serum than those observed after the same doses in volunteers. In the patients there was no build-up in serum levels between the first and fifth days. The data obtained explain the clinical efficacy of cefuroxime in the treatment of lower respiratory infections, and suggest that a 12-hour schedule may be feasible.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Daikos G. K., Kosmidis J. C., Stathakis C., Giamarellou H. Cefuroxime: antimicrobial activity, human pharmacokinetics and therapeutic efficacy. J Antimicrob Chemother. 1977 Nov;3(6):555–562. doi: 10.1093/jac/3.6.555. [DOI] [PubMed] [Google Scholar]
  2. Foord R. D. Cefuroxime: human pharmacokinetics.. Antimicrob Agents Chemother. 1976 May;9(5):741–747. doi: 10.1128/aac.9.5.741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. O'Callaghan C. H., Sykes R. B., Ryan D. M., Foord R. D., Muggleton P. W. Cefuroxime - a new cephalosporin antibiotic. J Antibiot (Tokyo) 1976 Jan;29(1):29–37. doi: 10.7164/antibiotics.29.29. [DOI] [PubMed] [Google Scholar]
  4. ROLINSON G. N., STEVENS S. Microbiological studies on a new broad-spectrum penicilin, "Penbritin". Br Med J. 1961 Jul 22;2(5246):191–196. doi: 10.1136/bmj.2.5246.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. van Dalen R., Vree T. B., Hafkenscheid J. C., Gimbrère J. S. Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency. J Antimicrob Chemother. 1979 May;5(3):281–292. doi: 10.1093/jac/5.3.281. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES